Translational research bridges the gap between laboratory discoveries and patient care by transforming scientific findings into practical medical treatments. Clinical trials are carefully designed studies that test new drugs, therapies, or interventions in people to determine their safety and effectiveness. Together, translational research and clinical trials accelerate the development of innovative healthcare solutions, ensuring that promising scientific advances lead to real-world improvements in diagnosis, treatment, and prevention of diseases.
Translational research bridges the gap between laboratory discoveries and patient care by transforming scientific findings into practical medical treatments. Clinical trials are carefully designed studies that test new drugs, therapies, or interventions in people to determine their safety and effectiveness. Together, translational research and clinical trials accelerate the development of innovative healthcare solutions, ensuring that promising scientific advances lead to real-world improvements in diagnosis, treatment, and prevention of diseases.
What is translational research?
Translational research turns basic scientific discoveries into medical applications that improve patient care, moving ideas from the lab to the clinic and the community.
What are clinical trials and why are they conducted?
Clinical trials are carefully designed studies in people that test new drugs, therapies, or interventions to assess safety and effectiveness before they can be approved for widespread use.
What are the main phases of clinical trials?
Phase I tests safety and dosing in a small group; Phase II looks at efficacy and side effects; Phase III compares the new treatment to standard care in larger groups; Phase IV monitors long-term safety after approval.
What safeguards protect participants in clinical trials?
Participants provide informed consent, trials obtain IRB/ethics committee approval, and safety is monitored throughout to protect rights and well-being.